Coronavirus (COVID-19) information for Dana-Farber patients & families Learn more
Please note that some translations using Google Translate may not be accurately represented and downloaded documents cannot be translated. Dana-Farber assumes no liability for inaccuracies that may result from using this third-party tool, which is for website translation and not clinical interactions. You may request a live medical interpreter for a discussion about your care.
Dr. Kim received his medical degree from Dartmouth Medical School in 2010. He completed postgraduate training in internal medicine in 2013 and a fellowship in medical oncology and hematology in 2017, both at the University of Massachusetts Medical School. For one year between internal medicine residency and fellowship, he was on staff as a physician in the Division of Hospital Medicine at Mount Auburn Hospital in Cambridge, Massachusetts. He joined the division of hematologic malignancies at Dana-Farber in 2017.
Austin Kim, MD, treats patients with non-Hodgkin lymphoma, Hodgkin lymphoma, and chronic lymphocytic leukemia (CLL). Kim expresses his optimism for medical research, which not only offers better treatment options, but also reduces side-effects and improves the quality of life. Learn more about the Adult Lymphoma program: http://www.dana-farber.org/lymphoma-program/
Dana-Farber Cancer Institute450 Brookline AvenueBoston, MA 02215Get Directions